Omnicell, Inc (OMCL) Files Form 4 Insider Selling : J Christopher Drew Sells 15,000 Shares

Omnicell, Inc (OMCL): J Christopher Drew , Exe VP, Sales & Marketing of Omnicell, Inc sold 15,000 shares on May 10, 2016. The Insider selling transaction was reported by the company on May 10, 2016 to the Securities and Exchange Commission. The shares were sold at $31.63 per share for a total value of $474,502.50 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on May 5, 2016, Sara J White (director) sold 2,000 shares at $31.76 per share price.On Apr 29, 2016, Robin Gene Seim (EVP, Global A & M Adherence) sold 6,407 shares at $31.00 per share price.Also, On Apr 26, 2016, Jorge R. Taborga (Executive VP. Engineering) sold 23,827 shares at $30.00 per share price.On Feb 22, 2016, Dan S Johnston (EVP-Chief Legal & Admin Off) sold 8,850 shares at $27.42 per share price.

Omnicell: On Friday, May 6, 2016 heightened volatility was witnessed in Omnicell which led to swings in the share price. The shares opened for trading at $30.96 and hit $31.55 on the upside , eventually ending the session at $31.49, with a gain of 0.96% or 0.3 points. The heightened volatility saw the trading volume jump to 1,87,373 shares. The 52-week high of the share price is $40.8 and the company has a market cap of $1,128 M . The 52-week low of the share price is at $25.06.

Omnicell Money Flow Index Chart

Company has been under the radar of several Street Analysts.Omnicell is Reiterated by Topeka Capital Markets to Buy while Lowering the Price Target of the company shares to $ 37 from a previous price target of $38 . The Rating was issued on Mar 21, 2016.

Omnicell Inc. (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company has two operating segments: Automation and Analytics and Medication Adherence. The Automation and Analytics segment is organized around the design manufacturing selling and servicing of medication and supply dispensing systems pharmacy inventory management systems and related software. The Medication Adherence segment primarily includes the manufacturing and selling of consumable medication blister cards packaging equipment and ancillary products and services. The Company’s products include OmniRx SinglePointe AnywhereRN OptiFlex MS OptiFlex CL AccuFlex Autobond AutoGen and SureSeal among others.

Leave a Reply

Omnicell - Is it time to Sell?

Top Brokerage Firms are advising their investors on Omnicell. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.